Guidelines for Antithrombotic Therapy

Thrombosis, an important complication of atherosclerosis and of various medical and surgical conditions, can be prevented and treated effectively by a variety of pharmacologic agents. With an update of previous editions publications, this book provides a summary of the 2004 American College of Chest Physicians (ACCP) recommendations, together with a brief review of the background data on which the recommendations are based. Literature searches were conducted by a recognized evidence-based center at McMaster University.

* Includes a new chapter addressing the management of patients who are treated with anti-coagulants or anti-platelet drugs
* Provides a detail summary to each chapter, documenting the therapeutic recommendations
* Updates on important clinical trials since last edition

Table of contents
Introduction
1: Grades of Recommendations for Antithrombotic Drugs
2: Heparin and Low-Molecular-Weight Heparin
3: Oral Anticoagulants (Vitamin K Antagonists)
4: Platelet-Active Drugs
5: New Anticoagulants
6: Heparin-Induced Thrombocytopenia
7: Prevention of Venous Thromboembolism
8: Treatment of Venous Thromboembolism Disease
9: Atrial Fibrillation
10: Valvular Heart Disease
11: Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
12: Antithrombotic Therapy for Coronary Artery Disease
13: Intravenous Thrombolysis in Acute Myocardial Infarction
14: Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
15: Coronary Artery Bypass Grafts
16: Antithrombotic Therapy in Peripheral Artery Occlusive Disease
17: Antithrombotic Therapy during Pregnancy
18: Antithrombotic Therapy in Children